$JNJ Q2 2020
- Rev $18.3B (-10.8% YoY)
   * Consumer Health: $3,296M (-7.0%)
   * Pharmaceutical: $10,752M (+2.1%)
   * Medical Devices: $4,288M (-33.9%)
- Non-GAAP EPS $1.67 (-35.3% YoY)

- 2020 Guidance: Revenues: $79.9B-81.4B (from $77.5B-80.5B)

https://t.co/4uO5hO6uZQ https://t.co/Uge39e15LA